BRIEF-Sangamo Therapeutics To Regain Full Rights To Hemophilia A Gene Therapy Program Following Pfizer’S Decision To Cease Development Of Giroctocogene Fitelparvovec
ReutersDec 30, 2024 9:26 PM
Dec 30 (Reuters) - Sangamo Therapeutics Inc SGMO.O:
SANGAMO THERAPEUTICS TO REGAIN FULL RIGHTS TO HEMOPHILIA A GENE THERAPY PROGRAM FOLLOWING PFIZER’S DECISION TO CEASE DEVELOPMENT OF GIROCTOCOGENE FITELPARVOVEC
SANGAMO THERAPEUTICS: INTENDS TO EXPLORE OPTIONS TO ADVANCE PROGRAM, INCLUDING SEEKING POTENTIAL NEW COLLABORATION PARTNER
SANGAMO THERAPEUTICS INC: COLLABORATION AND LICENSE AGREEMENT WITH PFIZER WILL TERMINATE EFFECTIVE APRIL 21, 2025
SANGAMO THERAPEUTICS INC: ALL TRIAL PARTICIPANTS WILL CONTINUE TO BE MONITORED AS PLANNED DURING TRANSITION PERIOD
Source text: ID:nBw35RTKxa
Further company coverage: SGMO.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
All Eyes on August CPI: The Data That Could Trigger a Jumbo Fed Cut — Or Not
TradingKey - The key question now is whether the August CPI report, to be released on September 11, could push the Fed toward a more aggressive 50-basis-point cut — as it did in September 2024.TradingKey
11 hours ago
Oracle Q1 FY2026 Earnings: Cloud Surge and Record RPO Fuel AI Optimism
TradingKey - Oracle Corporation (NYSE: ORCL) posted mixed Q1 FY2026 results, with total revenue and adjusted EPS slightly below consensus amid a shift to cloud services, but cloud revenue beat expectations with robust 28% growth. A massive RPO backlog of $455 billion, up 359% YoYTradingKey
Wed, Sep 10
U.S. August CPI Preview: Persistent Rise in Inflation, What Impact on Rate Cuts? And on US Stocks?
TradingKey - On 11 September 2025, the U.S. will publish August CPI data. Consensus forecasts indicate a 0.3% month-over-month increase for both headline CPI and core CPI. As a result, headline CPI year-over-year may climb to 2.9%, up from 2.7%TradingKey
Tue, Sep 9
Unlocking Gold’s Next Leg: $4,000 in Reach by 2025？
TradingKey - Gold has kicked off a fresh uptrend in early September, breaking out of months of compression and reclaiming key territory. The decisive move above $3,500 establishes a new support base and puts higher objectives back on the table for the weeks aheadTradingKey
Thu, Sep 4
2025 Hottest US IPO Week: Klarna, Gemini, Figure Set for “Triple Launch”
TradingKey - 5 companies are now pricing their U.S. initial public offerings (IPOs) for the week starting September 8, with a total expected fundraising exceeding $3 billion, making it the busiest IPO week of 2025. Investors are closely watching the debut performance of Klarna, Gemini, and Figure.TradingKey
Wed, Sep 3
Tradingkey
